Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1999 Oct;52(5):275–282. doi: 10.1136/mp.52.5.275

The integration of HPV-18 DNA in cervical carcinoma.

S A Corden 1, L J Sant-Cassia 1, A J Easton 1, A G Morris 1
PMCID: PMC395710  PMID: 10748877

Abstract

AIMS: Little information is available on the patterns of integration into the host chromosomal DNA of cervical carcinomas of human papillomavirus type 18 (HPV-18) DNA, which is associated with up to 20% of these carcinomas. Because integration of the viral genome may be extremely important in the pathogenesis of cervical carcinoma, the aim of this study was to investigate which regions of HPV-18 DNA are integrated into the cellular DNA of cervical carcinomas. METHODS: Southern analysis using four subgenomic probes covering the entire HPV-18 genome was used to map viral DNA integrated within cellular DNA. The polymerase chain reaction (PCR) was used to confirm the presence of specific regions of the viral genome. RESULTS: In all 11 carcinomas there was a single major HPV-18 DNA integrant, retaining approximately 4000 bp of HPV-18 DNA, indicating that approximately half of the virus genome had been lost upon integration. Southern analysis suggested strongly that the viral breakpoint was within the E1/E2 gene boundary, with concomitant loss of part or all of the E2 ORF (open reading frame), all of the E4, E5, and L2 ORFs and part of the L1 ORF. These data were supported by the PCR results, which confirmed that the region of integrated HPV-18 DNA from nucleotides 6558 to 162 was present in all the carcinoma samples studied. Assuming that no genomic rearrangements, deletions, or insertions had occurred, 4131 bp of integrated HPV-18 DNA could be accounted for in eight cervical carcinoma samples. The results of Southern analysis also suggested that integration of HPV-18 DNA may have occurred at a specific host chromosomal site. CONCLUSIONS: Broadly, the viral sequences retained upon HPV-18 integration resemble those found when HPV-16 is integrated. However, it appears that the HPV-18 E2 region is more consistently deleted.

Full Text

The Full Text of this article is available as a PDF (195.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berumen J., Casas L., Segura E., Amezcua J. L., Garcia-Carranca A. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer. 1994 Mar 1;56(5):640–645. doi: 10.1002/ijc.2910560506. [DOI] [PubMed] [Google Scholar]
  2. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1992. CA Cancer J Clin. 1992 Jan-Feb;42(1):19–38. doi: 10.3322/canjclin.42.1.19. [DOI] [PubMed] [Google Scholar]
  3. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  4. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984 May;3(5):1151–1157. doi: 10.1002/j.1460-2075.1984.tb01944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cartwright N. H., Cassia L. J., Easton A. J., Morris A. G. Detection of human papillomavirus in vulval carcinoma using semi-nested PCR and restriction enzyme typing: a rapid and sensitive technique. Clin Mol Pathol. 1996 Aug;49(4):M236–M239. doi: 10.1136/mp.49.4.m236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen C. M., Shyu M. P., Au L. C., Chu H. W., Cheng W. T., Choo K. B. Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach. J Med Virol. 1994 Oct;44(2):206–211. doi: 10.1002/jmv.1890440216. [DOI] [PubMed] [Google Scholar]
  7. Chong T., Chan W. K., Bernard H. U. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res. 1990 Feb 11;18(3):465–470. doi: 10.1093/nar/18.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choo K. B., Chen C. M., Han C. P., Cheng W. T., Au L. C. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions. J Med Virol. 1996 May;49(1):15–22. doi: 10.1002/(SICI)1096-9071(199605)49:1<15::AID-JMV3>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  9. Choo K. B., Lee H. H., Liew L. N., Chong K. Y., Chou H. F. Analysis of the unoccupied site of an integrated human papillomavirus 16 sequence in a cervical carcinoma. Virology. 1990 Oct;178(2):621–625. doi: 10.1016/0042-6822(90)90366-y. [DOI] [PubMed] [Google Scholar]
  10. Choo K. B., Lee H. H., Pan C. C., Wu S. M., Liew L. N., Cheung W. F., Han S. H. Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol. 1988 May;62(5):1659–1666. doi: 10.1128/jvi.62.5.1659-1666.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Choo K. B., Pan C. C., Han S. H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology. 1987 Nov;161(1):259–261. doi: 10.1016/0042-6822(87)90195-4. [DOI] [PubMed] [Google Scholar]
  12. Couturier J., Sastre-Garau X., Schneider-Maunoury S., Labib A., Orth G. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol. 1991 Aug;65(8):4534–4538. doi: 10.1128/jvi.65.8.4534-4538.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cullen A. P., Reid R., Campion M., Lörincz A. T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991 Feb;65(2):606–612. doi: 10.1128/jvi.65.2.606-612.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7824–7827. doi: 10.1073/pnas.79.24.7824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Daniel B., Mukherjee G., Seshadri L., Vallikad E., Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J Gen Virol. 1995 Oct;76(Pt 10):2589–2593. doi: 10.1099/0022-1317-76-10-2589. [DOI] [PubMed] [Google Scholar]
  16. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol. 1997 May;78(Pt 5):1095–1101. doi: 10.1099/0022-1317-78-5-1095. [DOI] [PubMed] [Google Scholar]
  17. Das B. C., Sharma J. K., Gopalakrishna V., Luthra U. K. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol. 1992 Sep;73(Pt 9):2327–2336. doi: 10.1099/0022-1317-73-9-2327. [DOI] [PubMed] [Google Scholar]
  18. Das B. C., Sharma J. K., Gopalkrishna V., Das D. K., Singh V., Gissmann L., zur Hausen H., Luthra U. K. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol. 1992 Apr;36(4):239–245. doi: 10.1002/jmv.1890360402. [DOI] [PubMed] [Google Scholar]
  19. Demeret C., Le Moal M., Yaniv M., Thierry F. Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic Acids Res. 1995 Dec 11;23(23):4777–4784. doi: 10.1093/nar/23.23.4777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gallego M. I., Lazo P. A. Deletion in human chromosome region 12q13-15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J Biol Chem. 1995 Oct 13;270(41):24321–24326. doi: 10.1074/jbc.270.41.24321. [DOI] [PubMed] [Google Scholar]
  21. Gloss B., Bernard H. U. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol. 1990 Nov;64(11):5577–5584. doi: 10.1128/jvi.64.11.5577-5584.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Iwasawa A., Nieminen P., Lehtinen M., Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer. 1996 Jun 1;77(11):2275–2279. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2275::AID-CNCR14>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  23. Kitagawa K., Yoshikawa H., Onda T., Kawana T., Taketani Y., Yoshikura H., Iwamoto A. Genomic organization of human papillomavirus type 18 in cervical cancer specimens. Jpn J Cancer Res. 1996 Mar;87(3):263–268. doi: 10.1111/j.1349-7006.1996.tb00215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lazo P. A. Structure, DNaseI hypersensitivity and expression of integrated papilloma virus in the genome of HeLa cells. Eur J Biochem. 1987 Jun 1;165(2):393–401. doi: 10.1111/j.1432-1033.1987.tb11452.x. [DOI] [PubMed] [Google Scholar]
  25. Lehn H., Villa L. L., Marziona F., Hilgarth M., Hillemans H. G., Sauer G. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol. 1988 Jan;69(Pt 1):187–196. doi: 10.1099/0022-1317-69-1-187. [DOI] [PubMed] [Google Scholar]
  26. Lorincz A. T., Reid R., Jenson A. B., Greenberg M. D., Lancaster W., Kurman R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992 Mar;79(3):328–337. doi: 10.1097/00006250-199203000-00002. [DOI] [PubMed] [Google Scholar]
  27. Matsukura T., Koi S., Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology. 1989 Sep;172(1):63–72. doi: 10.1016/0042-6822(89)90107-4. [DOI] [PubMed] [Google Scholar]
  28. May M., Dong X. P., Beyer-Finkler E., Stubenrauch F., Fuchs P. G., Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 1994 Mar 15;13(6):1460–1466. doi: 10.1002/j.1460-2075.1994.tb06400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mayor S. Human papilloma-virus classified as carcinogenic. BMJ. 1996 Jul 13;313(7049):70–70. doi: 10.1136/bmj.313.7049.70a. [DOI] [PubMed] [Google Scholar]
  30. Nakagawa S., Yoshikawa H., Onda T., Kawana T., Iwamoto A., Taketani Y. Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer. 1996 Nov 1;78(9):1935–1941. [PubMed] [Google Scholar]
  31. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. doi: 10.1002/ijc.2910540413. [DOI] [PubMed] [Google Scholar]
  32. Pater M. M., Pater A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology. 1985 Sep;145(2):313–318. doi: 10.1016/0042-6822(85)90164-3. [DOI] [PubMed] [Google Scholar]
  33. Schwab M., Varmus H. E., Bishop J. M., Grzeschik K. H., Naylor S. L., Sakaguchi A. Y., Brodeur G., Trent J. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature. 1984 Mar 15;308(5956):288–291. doi: 10.1038/308288a0. [DOI] [PubMed] [Google Scholar]
  34. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985 Mar 7;314(6006):111–114. doi: 10.1038/314111a0. [DOI] [PubMed] [Google Scholar]
  35. Shirasawa H., Tomita Y., Fuse A., Yamamoto T., Tanzawa H., Sekiya S., Takamizawa H., Simizu B. Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line. J Gen Virol. 1989 Jul;70(Pt 7):1913–1919. doi: 10.1099/0022-1317-70-7-1913. [DOI] [PubMed] [Google Scholar]
  36. Shirasawa H., Tomita Y., Kubota K., Kasai T., Sekiya S., Takamizawa H., Simizu B. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol. 1988 Mar;62(3):1022–1027. doi: 10.1128/jvi.62.3.1022-1027.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shirasawa H., Tomita Y., Sekiya S., Takamizawa H., Simizu B. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol. 1987 Feb;68(Pt 2):583–591. doi: 10.1099/0022-1317-68-2-583. [DOI] [PubMed] [Google Scholar]
  38. Steger G., Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol. 1997 Jan;71(1):50–58. doi: 10.1128/jvi.71.1.50-58.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tan S. H., Gloss B., Bernard H. U. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res. 1992 Jan 25;20(2):251–256. doi: 10.1093/nar/20.2.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tan S. H., Leong L. E., Walker P. A., Bernard H. U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol. 1994 Oct;68(10):6411–6420. doi: 10.1128/jvi.68.10.6411-6420.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wagatsuma M., Hashimoto K., Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol. 1990 Feb;64(2):813–821. doi: 10.1128/jvi.64.2.813-821.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wilczynski S. P., Pearlman L., Walker J. Identification of HPV 16 early genes retained in cervical carcinomas. Virology. 1988 Oct;166(2):624–627. doi: 10.1016/0042-6822(88)90539-9. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES